2 results
Approved WMOCompleted
The objective of this pilot study is to evaluate the impact of the FreeStyle InsuLinx on glycaemic control.
Approved WMOCompleted
To provide continued bevacizumab therapy as single agent or in combination with an anti-cancer drug to patients with cancer, who were previously enrolled in a F. Hoffmann-La Roche (Roche)/ Genentech sponsored bevacizumab study (i.e. the Parent, P-…